All News

UPS Healthcare, a leading logistics company in supply chain optimisation, has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at the CPHI Worldwide event in Barcelona in October 2023. 

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. 

Dr. Paul Lohmann® offers various Mineral Gluconates with API documentation - ASMFs and for Ferrous Gluconate a CEP - for the registration of a drug with the health authorities.

Discover what makes Pfizer CentreOne an Altogether Different Kind of CDMO.

Ahead of his session at CPHI Barcelona, which explores the current state of the CDMO landscape, Vinay Saluja (VS) – global head development services at Novartis Global Biotech Cooperations, contract manufacturing unit of Novartis – discusse...

The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. 

Introducing TSN Biopharma

TCG Greenchem discusses their innovative CDMO services

The PSCI have launched their framework for suppliers in the pharmaceutical and health industry for increasing social and environmental responsibility, complete with guides and resources, all showcased in a helpful webinar. 

Why Asymchem is your most reliable CDMO partner

After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. 

Pharmalink introduces their new non-invasive bladder cancer diagnostic test.

Oliver Healthcare introduces their new sustainable packing products in this infographic

The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). 

Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours.

Biospectra introduces their expertise in fine chemical manufacturing in this latest infographic, highlighting their ability to provide key ingredients and specialised solutions.

Olon, the leading CDMO and API supplier has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at the CPHI Worldwide event in Barcelona in October 2023. 

Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...

The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ...

In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. 

Adesis is a contract development and manufacturing organisation, working to solve chemical problems for their partners, and accelerate their research and development.

With more than 135 years of experience, Dr. Paul Lohmann® is an expert in high quality Salt manufacturing and provides DPL-BioPharm Salts for upstream, downstream and fill & finish processes of the biopharmaceutical industry.

The number one provider for medicated lozenges. Hard-boiled lozenges with galenIQ^TM 900 - the sweet filler-binder.

Discover more than 30 references under MDR certification and your next expert partners in the development of medical devices, food supplements, food for medical purposes, cosmetics, and in vitro medical devices.

The latest in a quarterly series of articles about responsible supply chain management from the PSCI, this time covering environmental concerns and the programmes in place to address them. 

CPHI releases its 2023 Sustainability Trend Report, working towards a greener future in the pharmaceutical industry.

Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. 

Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients.

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. This instalment highlights not only the importance of ma...

Ahead of her session on Next-Gen Biomanufacturing at CPHI Barcelona, Sheila Ann Mikhail (SM) – Co-Founder and Former CEO of AskBio – discusses gene therapy, AI and being an informed innovator when picking your manufacturing partner. 

CPHI Barcelona from 24–26 October at Fira Barcelona Gran Via, Spain will be your home for inspiration this year! 

Joining the strong number of cancer therapies being approved in 2023 is the CAR-T cell therapy from Invectys, the clinical-stage immuno-oncology company.

In the most recent instalment of the CPHI Podcast Series, Digital Editor Lucy Chard is joined by Sandra Sánchez y Oldenhage, President and CEO of PharmAdvice, to discuss nearshoring and reshoring in the pharmaceutical industry, and the subs...

Pharmaceutical companies are starting to acknowledge their responsibility to making access to medicine equitable to all, and Gilead Sciences are working towards their biggest commitment in this aspect, via a new initiative to enable health equity for A...

The latest appointments and promotions across the pharmaceutical supply chain.

Several big pharma companies have added their names to a letter challenging suppliers in the healthcare industry to pledge to sustainability targets. 

The pharmaceutical supply chain has encountered numerous disruptions in the last few years, impacting procurement, manufacturing, packaging, and distribution operations within the pharmaceutical industry. Read about the rise in calls for near/resh...

Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed. 

A quarterly series of articles about responsible supply chain management from the PSCI. 

Ardena and RiboPro have formed an alliance to boost their respective skills in manufacturing and producing nanoparticle and mRNA-based therapeutics to improve accessibility to this technology in the biotherapeutic landscape. 

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. 

Samsung Biologics agrees to use their biocampus Plant 4 for the manufacture of a line of products from Pfizer. 

Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires.

In the USA, President Joe Biden will be signing an executive order to expand access to contraception. 

Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre...

Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients.

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. 

In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond.  

Considering a recent Phase II trial, the FDA have granted accelerated approval to Roche and Genentech for their bispecfic therapeutic for the treatment of types of lymphoma. 

Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet...

A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. 

Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population. 

Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. 

The latest soft capsule technology from Roquette using modified pea starch as an alternative to gelatin. 

Novo Nordisk will invest 15.9 billion Danish kroner into the expansion of their existing API manufacturing facility.

Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts. 

CDMO joins United Nations Global Compact

CDMO honored as an exceptionally managed company

Pharma service provider further expands offerings for clinical development and manufacturing

Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research.

A new partnership has been formed this month between Quanticate, the global biometric clinical research organisation, and KPS Life, a global functional service provider offering clinical outsourcing solutions to biopharmaceutical and medical device and...

In this written panel discussion experts in manufacturing in the pharmaceutical supply chain comment on the manufacturing landscape, how sustainable practices are being incorporated more readily, the challenges associated with this and the overall adva...

Roche has announced their plans to divest from their legacy Genentech biologics manufacturing facility as part of a larger operations strategy after emailed letters were sent to facility employees informing them of the decision.

Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert...

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

Lexicon Pharmaceuticals aiming to commercialise their recently approved heart failure drug in June, after receiving approval from the US FDA based on significant findings from two Phase III trials. 

Digital Editor Lucy Chard goes through the bioconjugate journey in this latest podcast from the CPHI Podcast Series, from development to manufacturing, with two experts in the field from Abzena, Louise Duffy and Campbell Bunce. 

Alliance Healthcare UK aids in the camapign for support for the Medicines to Ukraine initiative, which aims to supply hospitals in the war-torn country with the vital medicines they need to treat casualties from the conflict. 

The life science service and instrument provider have opened their new Singapore-based steriles drug manufacturing facility with the goal of bringing increased development and manufacturing capabilities for critical medicines to the APAC region. 

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this r...

AbbVie and Genmab recently received approval from the US FDA for their joint venture, the blood cancer therapy epcoritamab, sold under the brand name EPKINLY. 

Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ...

Roche launches into a new agreement with Zion Pharma, a leading Chinese pharmaceutical company, to help develop and commercialise their flagship small molecule tyrosine kinase inhibitor, ZN-A-1041. 

Recipharm receives regulatory approval for the manufacture of a microbiome-based product for the prevention of Clostridioides difficile recurrent infection, under GenIbet Biopharmaceuticals and Seres Therapeutics. 

Funded by the Bill & Melinda Gates Foundation, the Virginia Commonwealth University-based research-related institute will use the grant to expand on its current capabilities of bringing lifesaving medications around the world, as well as working on 14 ...

The collaboration between the pharmaceutical giant and scientific technology provider will aim to bring rapid and localised services to areas around the globe that lack affordable advanced genomic testing for breast and lung cancer.

A newly developed search tool uses AI to understand patient needs and reccomend the best clinical trials for their treatment, whilst keeping physicians centered in the process to ensure the best care. 

Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners...

In this written panel discussion experts in the pharmaceutical packaging industry comment on the current state of sustainability in packaging, and what can be done to improve this in the future.

Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners...

The European Union’s pharmaceutical industry could face a serious change in operations after Brussels published a proposal for the revamping of certain laws governing the industry. 

In the April episode of the CPHI Podcast Series we have a focus on sustainability, where Digital Editor Lucy Chard finds out what it means to be a Chief Sustainability Officer in the pharmaceutical industry from Nic Hunt, Global Head of Sustainability ...

Biogen has announced that they have received approval from the US FDA for the amyotrophic lateral sclerosis (ALS) treatment, QALSODY™ (tofersen). This is the first approval of a treatment that targets a genetic cause of ALS. 

This year marks the 5th anniversary of CPHI North America regional events. To celebrate this remarkable achievement, the CPHI show team hosted The Art of Pharma Anniversary Ball at the illustrious Philadelphia Museum of Art, with a keynote speech from ...

Bormioli Pharma has been designing innovative packaging solutions for the pharmaceutical industry for 200 years; in this interview Andrea Sentimenti described how they keep current in today's pharmaceutical landscape and how they are implementing s...

Follow along for live updates from the Content team as we bring you the latest from CPHI North America 2023 - from session talks, panel discussions, interviews, and more, there's a lot to discover with CPHI Online at the Pennsylvania Convention Cen...

As we prepare for CPHI North America from April 25–27 in Philadelphia, USA, CPHI Online caught up with some of the track sponsors to discuss how the show connects vital players within the North American pharmaceutical landscape.   ...

In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. 

Merck and XtalPi Inc. collaborate on an AI-powered technology platform to predict the crystal morphologies of diabetic medication metformin HCl, validated by wet-lab experiments conducted with Merck’s expertise, in a ‘digital-first’ a...

Meet with Seqens team members at CPHi, April 25-27, 2023 to learn how we have extended services to rapidly and sustainably advance drug development. VISIT CPHI Booth 441 

Bora Pharmaceuticals, the international cGMP CDMO producing specialised pharmaceutical products such as sterile and non-sterile ophthalmics and nasal sprays for clinical use, is partnering with Celltrion Asia Pacific, subsidiary of Celltrion Group Inc.

Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. 

As we prepare for CPHI North America from April 25–27 in Philadelphia, USA, CPHI Online caught up with some of the track sponsors to discuss how the show connects vital players within the North American pharmaceutical landscape. 

NextPharma has completed their acquisition of a Norway-based manufacturing site, specialising in chewable tablet technologies for calcium/vitamin D3 from pharmaceutical giant Takeda.

GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker. 

Read the news

We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-...

In collaboration with Thermo Fisher Scientific, UCSF has opened a new manufacturing site aimed at accelerating advanced cell and gene therapies for cancer, rare diseases, and other illnesses.

A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Ingrid Vande Velde.

GSK has voluntarily opened the intellectual property rights on it's long-acting injectable HIV preventative medicine to three companies, so that they can make generic versions that will be more accessible to less-developed countries. 

Samsung Biologics, the leading end-to-end CDMO, is set to start building a new plant based in North Korea, to expand its biomanufacturing capabilties. 

What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? 

Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. 

The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, w...

Learn how to meet the demands of a modern industry with an integrated CDMO for tailor-made advanced Softgel technologies, and discover what our expansion into North America will mean for our production capacities and growth in our latest infographic.

Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. 

The HM Treasury in the UK has announced that they will be awarding the Medicines and Healthcare Products Regulatory Agency (MHRA) with £10 million to expedite the generation of new medicines for UK patients. 

Pfizer makes a bold move in the acquisition of innovative cancer therapy biotechnology company Seagen, the move means the doubling of their pipeline of early-stage therapeutics and gaining four leading ADC therapies. 

At Pharmapack 2023 in Paris we debuted a new and improved Start-Up Hub. The Hub included several start-up companies we are looking to support and make the event more accessible. 

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, which was held at CPHI Frankfurt, across the categories from digital innovation to CEO of the year. 

Pfizer makes a breakthrough in migraine treatment with the approval from the US FDA of its new drug Zavzpret™ (zavegepant) in the form of a nasal spray, which adds to their current portfolio of oral migraine prevention and treatment therapies.&nb...

An agreement signed between TricorBraun and BioBottles will give nutraceutical companies (and potentially pharmaceutical companies) in the US and Canada access to the industry’s first fully biodegradable packaging option.

Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 

The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health. 

The latest results from a Phase II clinial trial into Enhertu shows consistently promising results, with a durable response in patients with various HER2-expressing tumours. 

We interview the winners of the Pharmapack Europe Awards 2023, who were chosen by a jury, and each developed an innovative solution in the categories of Drug Delivery Innovation, Packaging Innovation, Sustainability Initiative, Eco-Design, and Patient-...

In an effort to protect against potential future global health emergencies, the government of the UK and Moderna have cemented a 10-year partnership for vaccine manufacturing and research.

This year at Pharmapack 2023 in Paris, France, the CPHI Online team interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in this field.